Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS20070073127 A1
Tipo de publicaciónSolicitud
Número de solicitudUS 11/604,499
Fecha de publicación29 Mar 2007
Fecha de presentación27 Nov 2006
Fecha de prioridad25 Sep 2002
También publicado comoUS7142901, US20040242980
Número de publicación11604499, 604499, US 2007/0073127 A1, US 2007/073127 A1, US 20070073127 A1, US 20070073127A1, US 2007073127 A1, US 2007073127A1, US-A1-20070073127, US-A1-2007073127, US2007/0073127A1, US2007/073127A1, US20070073127 A1, US20070073127A1, US2007073127 A1, US2007073127A1
InventoresMassi Kiani, Mohamed Diab, Ammar Al-Ali, Walter Weber
Cesionario originalKiani Massi E, Mohamed Diab, Ammar Al-Ali, Weber Walter M
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Parameter compensated physiological monitor
US 20070073127 A1
Resumen
A monitor has an optical input from which a spectral characteristic can be derived. The monitor also has a non-optical input from which a parameter can be determined. A compensation relationship is determined for the spectral characteristic based on the parameter. A physiological measurement is determined based on the spectral characteristic and the compensation relationship.
Imágenes(20)
Previous page
Next page
Reclamaciones(24)
1. A physiological monitor comprising:
an optical sensor providing a first sensor signal responsive to a plurality of wavelengths of optical radiation after attenuation by pulsatile blood flowing within a tissue site of a patient;
a non-optical sensor providing a second sensor signal corresponding to the patient;
a processor configured to derive a spectral characteristic of the tissue site from the first sensor signal;
calibration data relating the spectral characteristic to a blood gas parameter of the patient; and
a correction applied to the calibration data in response to the second sensor signal.
2. The physiological monitor according to claim 1:
wherein the non-optical sensor has a temperature sensing element, and
wherein the second sensor signal is responsive to a tissue site temperature.
3. The physiological monitor according to claim 2:
wherein the calibration data defines a Bezier curve having end points and corresponding control points, and
wherein the correction repositions the control points so as to generate a modified calibration curve.
4. A physiological monitor comprising:
a primary input responsive to optical properties of a tissue site of a patient;
a characteristic of the tissue site derived from the primary input;
a calibration curve relating the characteristic to a blood gas parameter for the patient;
a blood gas value derived from the primary input and the calibration curve;
a secondary input responsive to non-optical properties corresponding to the patient; and
a compensation applied to at least one of the calibration curve and the blood gas value in response to the secondary input so as to derive a compensated blood gas value that is more accurate than the blood gas value.
5. The physiological monitor according to claim 4 wherein the secondary input provides a measure of the patient's blood pH.
6. The physiological monitor according to claim 5 wherein the secondary input is a blood pH value manually entered through a user interface.
7. The physiological monitor according to claim 5 wherein the secondary input is an output from a blood pH monitor having a sensor in contact with the patient.
8. A physiological monitoring method comprising:
generating an optical measurement at a tissue site having pulsatile blood flow;
defining calibration data relating the optical measurement to a blood gas parameter corresponding to the pulsatile blood flow;
calculating the optical measurement and the calibration data with a processor so as to generate a blood gas value corresponding to the blood gas parameter;
providing a non-optical measurement corresponding to the tissue site; and
correcting at least one of the calibration data and the blood gas value according to the non-optical measurement.
9. The physiological monitoring method according to claim 8:
wherein generating comprises attaching an optical sensor to the tissue site; and
wherein providing comprises integrating a non-optical sensor element into the optical sensor so as to make the non-optical measurement.
10. The physiological monitoring method according to claim 9 wherein integrating comprises positioning a thermistor within the optical sensor so as to take a temperature measurement of the tissue site.
11. The physiological monitoring method according to claim 8 wherein providing comprises attaching a non-optical sensor to the tissue site.
12. The physiological monitoring method according to claim 11 wherein providing further comprises taking a temperature measurement of the tissue site.
13. The physiological monitoring method according to claim 8 wherein providing comprises manually inputting into the processor via a user interface a non-optical measurement value corresponding to the tissue site.
14. The physiological monitoring method according to claim 13 wherein manually inputting comprises entering a tissue temperature value on a keypad that is in communications with the processor.
15. A physiological monitoring method comprising:
generating a non-invasive measurement at a tissue site of a patient;
defining calibration data relating the non-invasive measurement to a blood gas parameter;
calculating with a processor a blood gas value corresponding to the non-invasive measurement;
providing an invasive measurement of the patient;
compensating the blood gas value according to the invasive measurement.
16. The physiological monitoring method according to claim 15 wherein providing comprises measuring a blood pH value for the patient.
17. The physiological monitoring method according to claim 16 wherein measuring comprises manually entering the blood pH value via a user interface into the processor.
18. The physiological monitoring method according to claim 16 wherein measuring comprises outputting the blood pH value from a pH monitor via an instrument interface to the processor.
19. A physiological monitor comprising:
an optical sensor means for providing a tissue site spectral characteristic for a patient;
a non-optical input means for providing a compensation parameter for the patient;
a calibration means for relating the spectral characteristic to an uncompensated blood gas parameter; and
a correction means responsive to the compensation parameter for generating a compensated blood gas parameter.
20. The physiological monitor according to claim 19 further comprising a processor for applying the correction means to the calibration means.
21. The physiological monitor according to claim 19 further comprising a processor for applying the correction means to the uncompensated blood gas parameter.
22. The physiological monitor according to claim 19 further comprising a user interface means for manually entering a value for the compensation parameter into the processor.
23. The physiological monitor according to claim 19 further comprising an instrument interface means for entering the compensation parameter from an external monitor into the processor.
24. The physiological monitor according to claim 19:
wherein the calibration means comprises a Bezier curve; and
wherein the correction means comprises a control means for altering the shape of the Bezier curve.
Descripción
    REFERENCE TO RELATED APPLICATIONS
  • [0001]
    The present application is a continuation of U.S. patent application Ser. No. 10/714,526, filed on Nov. 14, 2003 entitled “Parameter Compensated Pulse Oximeter”; which claims the benefit U.S. Provisional Application No. 60/426,638, filed Nov. 16, 2002, entitled “Parameter Compensated Physiological Monitor,” and is a continuation-in-part of U.S. patent application Ser. No. 10/671,179, filed Sep. 25, 2003, entitled “Parameter Compensated Pulse Oximeter,” which claims the benefit of U.S. Provisional Application No. 60/413,494, filed Sep. 25, 2002, entitled “Parameter Compensated Pulse Oximeter.” The present application incorporates the disclosures of the foregoing applications herein by reference.
  • BACKGROUND OF THE INVENTION
  • [0002]
    Pulse oximetry is a noninvasive, easy to use, inexpensive procedure for measuring the oxygen saturation level of arterial blood. Pulse oximeters perform a spectral analysis of the pulsatile component of arterial blood in order to determine the relative concentration of oxygenated hemoglobin, the major oxygen carrying constituent of blood, and reduced hemoglobin. These instruments have gained rapid acceptance in a wide variety of medical applications, including surgical wards, intensive care units, general wards and home care by providing early detection of decreases in the arterial oxygen supply, which reduces the risk of accidental death and injury.
  • [0003]
    FIG. 1 illustrates a pulse oximetry system 100 having a sensor 110 and a monitor 150. The sensor 110 has emitters 120 and a detector 130. The emitters 120 typically consist of a red light emitting diode (LED) and an infrared LED that project light through blood vessels and capillaries underneath a tissue site, such as a fingernail bed. The detector 130 is typically a photodiode positioned opposite the LEDs so as to detect the emitted light as it emerges from the tissue site. A pulse oximetry sensor is described in U.S. Pat. No. 6,088,607 entitled “Low Noise Optical Probe,” which is assigned to Masimo Corporation, Irvine, Calif. and incorporated by reference herein.
  • [0004]
    Also shown in FIG. 1, the monitor 150 has drivers 152, a sensor front-end 154, a signal processor 155, a display driver 157, a display 158 and a controller 159. The drivers 152 alternately activate the emitters 120 as determined by the controller 159. The front-end 154 conditions and digitizes the resulting current generated by the detector 130, which is proportional to the intensity of the detected light. The signal processor 155 inputs the conditioned detector signal and determines oxygen saturation based upon the differential absorption by arterial blood of the two wavelengths projected by the emitters 120. Specifically, a ratio of detected red and infrared intensities is calculated by the signal processor 155, and an arterial oxygen saturation value is empirically determined based on the ratio obtained, as described with respect to FIGS. 2-3, below. The display driver 157 and associated display 158 indicate a patient's oxygen saturation along with pulse rate.
  • [0005]
    The Beer-Lambert law provides a simple model that describes a tissue site response to pulse oximetry measurements. The Beer-Lambert law states that the concentration ci of an absorbent in solution can be determined by the intensity of light transmitted through the solution, knowing the pathlength dλ, the intensity of the incident light Io,λ, and the extinction coefficient Ei,λ at a particular wavelength λ. In generalized form, the Beer-Lambert law is expressed as: I λ = I 0 , λ - d λ · μ a , λ ( 1 ) μ a , λ = i = 1 n ɛ i , λ · c i ( 2 )
    where μa,λ is the bulk absorption coefficient and represents the probability of absorption per unit length. The Beer-Lambert law assumes photon scattering in the solution is negligible. The minimum number of discrete wavelengths that are required to solve EQS. 1-2 are the number of significant absorbers that are present in the solution. For pulse oximetry, it is assumed that wavelengths are chosen such that there are only two significant absorbers, which are oxygenated hemoglobin (HbO2) and reduced hemoglobin (Hb).
  • [0006]
    FIG. 2 illustrates top-level computation functions for the signal processor 155 (FIG. 1), described above. In particular, pulse oximetry measurements are conventionally made at a red wavelength corresponding to 660 nm and an infrared wavelength corresponding to 940 nm. At these wavelengths, reduced hemoglobin absorbs more red light than oxygenated hemoglobin, and, conversely, oxygenated hemoglobin absorbs more infrared light than reduced hemoglobin.
  • [0007]
    In addition to the differential absorption of hemoglobin derivatives, pulse oximetry relies on the pulsatile nature of arterial blood to differentiate hemoglobin absorption from absorption of other constituents in the surrounding tissues. Light absorption between systole and diastole varies due to the blood volume change from the inflow and outflow of arterial blood at a peripheral tissue site. This tissue site also comprises skin, muscle, bone, venous blood, fat, pigment, etc., each of which absorbs light. It is assumed that the background absorption due to these surrounding tissues is invariant and can be ignored. That is, the sensor signal generated by the pulse-added arterial blood is isolated from the signal generated by other layers including tissue, venous blood and baseline arterial blood.
  • [0008]
    As shown in FIG. 2, to isolate the pulsatile arterial blood, the signal processor 155 (FIG. 1) computes ratios 215, 265 of the AC portions 212, 262 of the detected red (RD) 201 and infrared (IR) 206 signals with respect to the DC portions 214, 264 of the detected signals 201, 206. Computations of these AC/DC ratios 215, 265 provide relative absorption measures that compensate for variations in both incident light intensity and background absorption and, hence, are responsive only to the hemoglobin in the arterial blood. Further, a ratio of the normalized absorption at the red wavelength over the normalized absorption at the infrared wavelength is computed:
    RD/IR=(Red AC /Red DC)/(IR AC/IRDC)  (3)
    The desired oxygen saturation (SpO2) 282 is then computed empirically from this “red-over-infrared, ratio-of-ratios” (RD/IR) 272. That is, the RD/IR output 272 is input to a look-up table 280 containing empirical data 290 relating RD/IR to SpO2, as described with respect to FIG. 3, below.
  • [0009]
    FIG. 3 shows a graph 300 depicting the relationship between RD/IR and SpO2. This relationship can be approximated from Beer-Lambert's Law, described above. However, it is most accurately determined by statistical regression of experimental measurements obtained from human volunteers and calibrated measurements of oxygen saturation. The result can be depicted as a curve 310, with measured values of RD/IR shown on a x-axis 302 and corresponding saturation values shown on an y-axis 301. In a pulse oximeter device, this empirical relationship can be stored in a read-only memory (ROM) for use as a look-up table 280 (FIG. 2) so that SpO2 can be directly read-out from an input RD/IR measurement. For example, an RD/IR value of 1.0 corresponding to a point 312 on the calibration curve 310 indicates a resulting SpO2 value of approximately 85%.
  • SUMMARY OF THE INVENTION
  • [0010]
    Conventional pulse oximetry measurements, for example, depend on a predictable, empirical correlation between RD/IR and SpO2. The relationship between oxygen saturation and tissue spectral characteristics, such as RD absorbance as compared with IR absorbance, however, vary with other parameters such as site temperature, pH and total hematocrit (Hct), to name just a few, that are not accounted for in the conventional photon absorbance model. A parameter compensated physiological monitor advantageously utilizes one or more parameters that are not considered in conventional physiological monitoring in order to derive a more accurate physiological measurement. Parameters may be input from various sources, such as multiple parameter sensors, additional sensors, external instrumentation and manual input devices. A compensated physiological measurement accounts for these parameters by various mechanisms including modification of calibration data, correction of uncompensated physiological measurements, multidimensional calibration data, sensor wavelength modification in conjunction with wavelength-dependent calibration data, and modification of physiological measurement algorithms.
  • [0011]
    One aspect of a parameter compensated physiological monitor has a primary input from which a spectral characteristic of a tissue site can be derived. The monitor also has a secondary input from which at least one parameter can be determined. A compensation relationship of the spectral characteristic, the parameter and a compensated physiological measurement is determined. A processor is configured to output the compensated physiological measurement in response to the primary input and the secondary input utilizing the compensation relationship.
  • [0012]
    A parameter compensated physiological monitoring method includes the steps of inputting a sensor signal responsive to a spectral characteristic of a tissue site and deriving a physiological measurement from the characteristic. Other steps include obtaining a parameter, wherein the physiological measurement has a dependency on the parameter and determining a relationship between the spectral characteristic and the parameter that accounts for the dependency. A further step is compensating the physiological measurement for the parameter utilizing the relationship.
  • [0013]
    Another aspect of a parameter compensated physiological monitor has a primary input for determining a spectral characteristic associated with a tissue site. The monitor also has a secondary input means for determining a parameter that is relevant to measuring oxygen saturation at the tissue site and a compensation relationship means for relating the spectral characteristic, the parameter and an oxygen saturation measurement.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0014]
    FIG. 1 is a block diagram of a prior art pulse oximeter;
  • [0015]
    FIG. 2 is a top-level functional diagram of conventional pulse oximetry signal processing;
  • [0016]
    FIG. 3 is an exemplar graph of a conventional calibration curve;
  • [0017]
    FIG. 4 is a top-level block diagram of a parameter compensated physiological monitor having sensor, external instrument and manual parameter inputs;
  • [0018]
    FIG. 5 is a block diagram of a parameter compensated pulse oximeter having a manual parameter input;
  • [0019]
    FIG. 6 is a block diagram of a parameter compensated pulse oximeter having a multi-wavelength sensor along with sensor site temperature and external instrument pH parameter inputs;
  • [0020]
    FIG. 7 is a top-level functional block diagram of a compensation relationship having spectral characteristic and parameter inputs and a compensated physiological measurement output;
  • [0021]
    FIG. 8A is a functional block diagram of parameter compensated signal processing incorporating calibration data modification;
  • [0022]
    FIG. 8B is a functional block diagram of compensated pulse oximetry incorporating an SpO2 parameter input and SpO2 measurement feedback;
  • [0023]
    FIG. 8C is a functional block diagram of pulse oximetry calibration data modification;
  • [0024]
    FIGS. 9A-D are graphs of one embodiment of calibration data modification utilizing Bezier curves;
  • [0025]
    FIG. 10A is a functional block diagram of parameter compensated signal processing incorporating physiological measurement correction;
  • [0026]
    FIG. 10B is a functional block diagram of compensated pulse oximetry incorporating a hemoglobin constituent correction for a SpO2 measurement;
  • [0027]
    FIG. 11 is a functional block diagram of parameter compensated signal processing incorporating multidimensional calibration data;
  • [0028]
    FIG. 12 is a graph of a multidimensional calibration surface for a compensated physiological measurement;
  • [0029]
    FIG. 13A is a functional block diagram of parameter compensated signal processing incorporating sensor wavelength modification and wavelength-dependent calibration data;
  • [0030]
    FIG. 13B is a functional block diagram of compensated pulse oximetry incorporating a null parameter and SpO2 feedback; and
  • [0031]
    FIG. 14 is a functional block diagram of compensated pulse rate measurements.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • [0000]
    Overview
  • [0032]
    Parameter compensated physiological monitoring is described below with respect to monitor interface architectures (FIGS. 4-6) and monitor signal processing functions (FIGS. 7-14). FIG. 4 illustrates a general interface architecture including a primary sensor input and parameter inputs from sensors, external instruments and manual entry. FIGS. 5-6 illustrate particular pulse oximetry embodiments of FIG. 4. FIG. 5 illustrates a two-wavelength sensor input along with manual parameter inputs. FIG. 6 illustrates a multiple wavelength sensor allowing derived parameters, a sensor temperature element input for a site temperature parameter, and an external instrument input for a pH parameter.
  • [0033]
    FIG. 7 illustrates a general parameter compensation signal processing function. FIGS. 8-9 illustrate a compensated physiological measurement computed from a spectral characteristic utilizing parameter modified calibration data. FIGS. 10A-B illustrate a compensated physiological measurement computed from parameter dependent correction of an uncompensated physiological measurement. FIGS. 11-12 illustrate a compensated physiological measurement computed from a spectral characteristic and input parameters utilizing multidimensional calibration data. FIGS. 13A-B illustrate a compensated physiological measurement resulting from parameter dependent sensor wavelength and calibration data modification. FIG. 14 illustrates a compensated physiological measurement computed from a parameter modified algorithm.
  • [0034]
    The interface architectures according to FIGS. 4-6 may each support signal processing functions according to FIGS. 7-14. As just one of many examples and embodiments, a pulse oximeter has a manual input compensation parameter, such as described with respect to FIG. 5. The manual input may be, say, a blood gas derived parameter, such as carboxyhemoglobin (HbCO) or methemoglobin (MetHb) to name just a few. This parameter is utilized to select, modify, derive or otherwise determine a calibration curve or other form of calibration data so as to compute a more accurate measure of SpO2.
  • [0000]
    Parameter Compensation Architecture
  • [0035]
    FIG. 4 illustrates a parameter compensated physiological monitor 400 having a sensor interface 410, an external instrument interface 420 and a user interface 430. The sensor interface 410 connects to one or more tissue site sensors 10, which may be optical or non-optical devices configured to provide invasive or noninvasive measurements of tissue site properties. The sensor interface 410 has a primary input 412 and one or more sensor parameter inputs 414. The primary input 412 is adapted to provide tissue site spectral characteristics via sensor optical elements. A sensor parameter input 414 is adapted to provide other tissue site characteristics via optical or nonoptical elements.
  • [0036]
    In one embodiment, the primary input 412 is a detector response to at least two emitter wavelengths after transmission through or reflection from a tissue site, from which the physiological monitor 400 may derive at least a conventional physiological measurement, such as an oxygen saturation value, as described with respect to FIGS. 1-3 above. An example of this embodiment is described with respect to FIG. 5, below. In another embodiment, the sensor 10 utilizes more than two wavelengths so that the physiological monitor 400 may derive, for example, the concentrations of other blood constituents in addition to oxygen saturation, such as total hematocrit (Hct). The same sensor or a different sensor may also provide other tissue site measurements, such as temperature, on the sensor parameter input 414. An example of this embodiment is described with respect to FIG. 6, below.
  • [0037]
    Also shown in FIG. 4, an external instrument interface 420 connects to one or more external instruments 20, which may monitor physiological or nonphysiological properties, invasively or noninvasively, from the sensor tissue site or from other portions of a patient or a patient's immediate environment. In one embodiment, the external instrument 20 is a pH monitor, as described with respect to FIG. 6, below.
  • [0038]
    Further shown in FIG. 4, a user interface 430 accepts one or more manual input parameters 432. As an example, the user interface 430 may be a keyboard input operating in conjunction with a user display, which may range from a small character display to a CRT providing a computer-generated graphical user interface (GUI). The manual inputs may be any information related to, for instance, a patient, a patient's immediate environment, or a patient's medical history. In one embodiment, a manual input 432 may indicate the presence of an implant device, such as a pacemaker or an intra aortic balloon pump (IABP). In another embodiment, a manual input of blood gas measurements, such as are obtainable from a CO-oximeter, is provided.
  • [0039]
    Additionally shown in FIG. 4, the sensor interface 410, external instrument interface 420 and user interface 430 each provide inputs to the signal processor 440. The signal processor utilizes the primary input 412 and one or more parameter inputs 403 to generate a compensated physiological measurement 442. In one embodiment, the compensated physiological measurement 442 is an SpO2 value that is derived from both the primary input 412 and the parameter inputs 403.
  • [0040]
    FIG. 5 illustrates one embodiment of a parameter compensated physiological monitor 400 (FIG. 4). A parameter compensated pulse oximeter 500 has sensor 510 and manual inputs. In particular, drivers 562 activate emitters 520 that project two wavelengths into a tissue site, and a detector 540 responsive to the emitters 520 provides a primary input 542 to a sensor front-end 564, as described above. A user interface 565 accepts manual inputs 550 such as temperature (T), pH, Hct, HbCO and MetHb, etc. The sensor front-end 564 and user interface 565 output to the signal processor 566 a detector signal along with the manually input parameters. The signal processor 566 computes a compensated SpO2 measurement from the detector signal and these parameters, as described with respect to FIGS. 7-13, below. The compensated SpO2 measurement is then displayed 567, 568 in a manner similar to that described above with respect to FIG. 1.
  • [0041]
    FIG. 6 illustrates another embodiment of a parameter compensated physiological monitor 400 (FIG. 4). A parameter compensated multiple wavelength monitor 600 has inputs from a sensor 610 and an external pH monitor 650. The sensor 610 has multiple wavelength emitters 620 and a site temperature element 630. Multiple wavelengths may be achieved, for example, by utilizing multiple LEDs each manufactured for a specific wavelength according to the number of wavelengths desired. Alternatively, one or more LEDs having drive current dependent wavelengths may be utilized, where the drive current is controlled to shift between multiple wavelengths. The site temperature element 630 provides a site temperature parameter input to the sensor front-end 664. In one embodiment, the site temperature element 630 is a thermistor located on the sensor 610 proximate the emitters 620 or proximate the detector 640. The detector 640 provides a multiple wavelength signal output that is combined with a site temperature output to a sensor front-end 664. An instrument interface 665 is adapted to input pH readings from the pH monitor 650. The sensor drivers 662 provide multiplexed activation of the multiple emitters 620 as determined by the controller 669. The signal processor 666 accepts outputs from the sensor front-end 664 and the instrument interface 665. In addition, the signal processor 666 computes an SpO2 measurement from the detector signal along with a sensor parameter, such as Hct for example, utilizing the multiple wavelength signal from the detector 640. Further, the signal processor 666 derives a compensated SpO2 measurement from the site temperature, pH, and Hct parameters, as described with respect to FIGS. 7-13, below. The compensated SpO2 measurement is then displayed 667, 668 in a manner similar to that described above.
  • [0042]
    As shown in FIG. 6, a pulse oximetry sensor 610 may be improved for use in conjunction with a parameter compensated pulse oximeter by increasing the number of wavelengths projected by the emitters 620, which allows the resolution of more than two blood constituents, as described above. Further, the sensor 610 may be improved by adding the capability to measure various parameters, such as site temperature. Alternatively, as shown in FIG. 5, pulse oximeter performance can be improved at reduced costs by utilizing simple sensors in conjunction with other instrumentation and/or manual inputs to provide additional input parameters.
  • [0043]
    The sensor 610 may also have an information element (not shown) that describes information regarding the sensor. In one embodiment, the information element provides the monitor 660 with information regarding available wavelengths for the emitters 620 and/or information regarding the temperature element 630, such as the resistance-temperature characteristics of a thermistor. An information element is described in U.S. Pat. No. 6,011,986 entitled “Manual And Automatic Probe Calibration,” assigned to Masimo Corporation, Irvine, Calif. and incorporated by referenced herein.
  • [0000]
    Parameter Compensation Signal Processing
  • [0044]
    FIG. 7 illustrates a compensation relationship function 700 that the signal processor 440 (FIG. 4) performs. The compensation relationship 700 has a spectral characteristic input or inputs 702 and parameter inputs 704 and generates a compensated physiological measurement output 708. The spectral characteristic 702 is derived from the primary input 412 (FIG. 4), the parameters 704 are received from the interfaces 410-430 (FIG. 4), and the physiological measurement 708 is provided at the signal processor output 442 (FIG. 4), as described above. FIGS. 8-14, below, illustrate various embodiments of the compensation relationship 700. FIGS. 8-9 illustrate a compensation relationship incorporating parameter modification of baseline calibration data. FIGS. 10A-B illustrate parameter correction of an uncompensated physiological measurement. FIGS. 11-12 illustrate parameter incorporation into multidimensional calibration data. FIGS. 13A-B illustrate parameter modification of sensor wavelength and selection of wavelength-dependent calibration data. FIG. 14 illustrates parameter modification of physiological measurement algorithms.
  • [0045]
    FIG. 8A illustrates a compensation relationship 800 having a look-up table 810, baseline calibration data 830 and a calibration data modification function 820. The compensation relationship 800 has a spectral characteristic input 802, parameter inputs 804 and a physiological measurement output 808, as described above. The calibration data modification 820 advantageously responds to the parameters 804 to select, modify, derive or otherwise determine from the baseline calibration data 830 a calibration data input 822 to the look-up table 810. The look-up table 810 uses the calibration data 822 to determine the physiological measurement 808 corresponding to the spectral characteristic 802. The calibration data 822 may also be responsive to feedback of the physiological measurement 808. The baseline calibration data 830 may be determined by statistical regression of experimental measurements obtained from human volunteers and calibrated measurements of the physiological measurement and associated parameters. Also, all or part of the look-up table 810, calibration data modification 820 and baseline calibration data 830 may be replaced by or combined with a mathematical formula or algorithm, theoretically or experimentally derived, that is used to compute calibration data or used to directly compute the physiological measurement from the spectral characteristic and parameter inputs.
  • [0046]
    FIGS. 8B-C describe one pulse oximeter embodiment of the compensation relationship 800 (FIG. 8A). As shown in FIG. 8B, the blood gas compensation relationship 851 has an RD/IR input 802 and generates an SpO2 output 808 utilizing baseline calibration data 880 that is modified according to an input value of arterial oxygen saturation SpO2. The compensation relationship 851 has a calibration data modification function 871 that provides modified calibration data 872 to a look-up table 860, as described with respect to FIG. 8A, above.
  • [0047]
    As shown in FIG. 8C, the calibration data modification 871 has comparison 891 and sensitivity filter 893 functions that input to modification rules 895 that operate on the baseline calibration data 882 to provide modified calibration data 872. The comparison 891 determines a difference between SpO2 804 and SpO2 808 so that the compensation relationship 871 can function to reduce the discrepancy between blood gas measurement and pulse oximeter measurements of oxygen saturation.
  • [0048]
    The responsiveness to blood gas measurements is determined by a sensitivity filter 893 and sensitivity adjustment 809. So as to reduce over-sensitivity of a calibration data to blood gas measurements, calibration data modification may require multiple blood gas input values over a range of saturation values and/or consistency within a tolerance range before calibration data is modified. Also, calibration data modification can be less sensitive to more frequently occurring normal saturation values and more sensitive to the less frequently occurring low saturation values. Hence, the sensitivity filter 893 may have a blood gas input 804 so that responsiveness varies with the range of blood gas sample values. Further, calibration data may be piecewise modified according to ranges of saturation values, so that an entire range of calibration data is not affected by blood gas measurements that are limited to a certain range of saturation values.
  • [0049]
    TABLE 1, below, illustrates one embodiment of the modification rules 895. Saturation Range is a range of blood gas measurements and a corresponding portion of the calibration curve to be replaced or modified. Number of Samples is the number of blood gas measurements required within the corresponding Saturation Range before a calibration curve modification or replacement is made. Sample Tolerance is the deviation allowed between measured SpO2 and measured SpO2 for a particular blood gas measurement to be considered. For example, the saturation ranges may be in 5% increments, i.e. 100-95%, 95-90%, etc. The number of samples may be, say, 4 for saturation measurements above 75% and 1 for saturation measurements below 75%. The sample tolerance may be SpO2-SpO2=±1%.
    TABLE 1
    Calibration Data Modification Rules
    SATURATION RANGE NUMBER OF SAMPLE
    (%) SAMPLES TOLERANCE
    100-x1 n1 Δ1
    x1-x2 n2 Δ2
    . . .
    . . .
    . . .
    xi-50 ni Δi
  • [0050]
    Depending on the embodiment, the modification rules 895 may operate on the baseline calibration data to select one of a family of calibration curves, determine the direction and amount of shift in a calibration curve, modify the shape of a calibration curve, rotate a calibration curve around a selected point on the curve, specify one or more points from which a calibration curve may be derived, or a combination of these actions. In this manner a pulse oximeter may be calibrated on site for individual patients, for improved accuracy as compared with total reliance on empirical calibration data derived from many individuals. Calibration curve modification in response to blood gas measurements is described in further detail with respect to FIGS. 9A-D, below.
  • [0051]
    FIGS. 9A-D illustrate calibration data modification utilizing a Bezier curve. In its most common form, a Bezier curve is a simple cubic equation defined by four points including the end points and two control points, as is well-known in the art. As shown in FIG. 9A a calibration curve 910, such as described with respect to FIG. 3, above can be approximated as a Bezier curve with an associated first control point 920 and second control point 930.
  • [0052]
    As shown in FIG. 9B, the initial Bezier curve 910 (FIG. 9A) can be modified in response to a blood gas measurement providing a first calibration point 940 at a relatively high saturation value. In particular, a modified calibration curve 911 can be derived in response to the first calibration point 940 by repositioning the first and second control points 920-930 so that the modified calibration curve 911 more closely approximates the first calibration point 940 than the original calibration curve 910 without significantly altering the original calibration curve 910 (FIG. 9A) within saturation ranges away from the first calibration point 940.
  • [0053]
    As shown in FIG. 9C, the modified calibration curve 911 (FIG. 9B) can be modified in response to a second calibration point 950 at a relatively low saturation value. In particular, a modified calibration curve 912 can be derived in response to the first and second calibration points 940-950 by again repositioning the first and second control points 920-930 so that the modified calibration curve 912 more closely approximates the calibration points 940-950.
  • [0054]
    As shown in FIG. 9D, the modified calibration curve 912 (FIG. 9C) can be modified yet again in response to a third calibration point 960. In particular, a modified calibration curve 913 can be derived in response to the three calibration points 940-960 by further repositioning the control points 920-930 so that the modified calibration curve 913 more closely approximates the calibration points 940-960.
  • [0055]
    Multiple calibration points may be accommodated by curve-fitting algorithms well-known in the art, such as a least-means-squared computation of the error between the modified calibration curve and the calibration points, as one example. Other polynomials curves may be used to derive modified calibration curves, and two or more sections of Bezier curves or other polynomial curves can be used to represent a modified calibration curve.
  • [0056]
    FIG. 10A illustrates a measurement correction compensation relationship 1000 having a look-up table 1010, calibration data 1020, and a measurement correction function 1030. The compensation relationship 1000 differs from the compensation relationship 800 (FIG. 8A) described above in that, an uncompensated physiological measurement 1018 is calculated and corrected to yield a compensated physiological measurement 1008. This contrasts with a compensated physiological measurement being directly derived from a spectral characteristic and parameters, as described with respect to FIG. 8A, above.
  • [0057]
    FIG. 10B illustrates an upgrade compensation relationship 1001 embodiment of the compensation relationship 1000 (FIG. 10A) described above. The compensation relationship 1001 advantageously upgrades the uncompensated oxygen saturation measurement of a conventional pulse oximeter. In particular, the look-up table 1010 and calibration curve 1020 may be as described with respect to FIGS. 2-3, above. In one embodiment, the measurement correction 1031 is a look-up table having a correction data set as input, where the correction data set is determined by statistical regression of experimental measurements obtained from human volunteers and calibrated measurements of oxygen saturation and associated parameters. In another embodiment, the measurement correction 1031 is a mathematical formula or algorithm that directly computes a compensated SpO2 output from uncompensated SpO2 and parameter inputs. In yet another embodiment, the measurement correction is a combination of look-up table and mathematical formula or algorithm. The compensation parameters may be, for example, one or more of T, pH, Hct, HbCO, MetHb, to name a few.
  • [0058]
    FIG. 11 illustrates a multidimensional calibration function 1100 having a look-up table 1110 and associated multidimensional calibration data 1120. The look-up table 1110 has a spectral characteristic input 1112, such as RD/IR, and one or more compensation parameters 1114, such as T, pH, Hct, HbCO, MetHb, etc., as described with respect to FIG. 7, above. In response to the spectral characteristic 1112 and parameter 1114 inputs, the look-up table 1110 provides a physiological measurement output 1118, such as a compensated oxygen saturation value, also as described with respect to FIG. 7, above. The look-up table 1110 may function as a calibration surface 1210 (FIG. 12) in a somewhat analogous manner to the calibration curve described with respect to FIG. 3, above. The multidimensional calibration data 1120 may be determined by statistical regression of experimental measurements obtained from human volunteers and calibrated measurements of the physiological measurement and associated parameters. Also, the look-up table 1110 and calibration data 1120 may be replaced by or combined with a mathematical formula or algorithm, theoretically or experimentally derived, used to directly compute a physiological measurement from spectral characteristic and parameter inputs.
  • [0059]
    FIG. 12 is a three-dimensional graph 1200 illustrating the look-up table calibration function described with respect to FIG. 11, above. The graph 1200 has an x-axis 1201 representing derived spectral characteristic values, a y-axis 1203 representing a parameter value, and a z-axis 1205 representing physiological measurement values that result from locating a position on the surface 1210 corresponding to a combination of spectral characteristic and parameter values. The three-dimensional graph 1200 may be extended to accommodate multiple parameters, so as to create a calibration surface in multidimensional hyperspace.
  • [0060]
    In one advantageous embodiment, a blood gas measurement of HbCO and/or MetHb is manually entered into a pulse oximeter and utilized to generate a compensated value of SpO2. As described above, conventional pulse oximetry utilizes two wavelengths, assuming that Hb and HbO2 are the only significant absorbers. However, HbCO and MetHb may also be significant absorbers at RD and IR wavelengths. The presence of significant concentrations of HbCO and MetHb have different effects on a conventional pulse oximeter estimate of oxygen saturation. HbO2 and HbCO have similar extinctions at the RD wavelength, as do MetHb and Hb. At the IR wavelength, HbCO is relatively transparent whereas MetHb has greater extinction than the other hemoglobins. The two wavelength assumption tends to lump HbO2 and HbCO together, i.e. HbCO is counted as an oxygen carrying form of hemoglobin, causing a conventional pulse oximeter to overestimate oxygen saturation. As MetHb increases, RD/IR tends to unity and SpO2 tends to a constant (e.g. 85%) regardless of oxygen saturation. A manually entered value of HbCO and or MetHb is used as a parameter in conjunction with the functions described above with respect to any of FIGS. 7-11, so as to distinguish these hemoglobin species from HbO2 and Hb, providing a more accurate, HbCO and/or MetHb compensated, value of SpO2.
  • [0061]
    FIG. 13A illustrates a wavelength compensation relationship 1300 having a look-up table 1310, wavelength-dependent calibration data 1320, and a wavelength determination function 1330. The wavelength compensation relationship 1300 advantageously changes sensor wavelength to generate a wavelength-compensated physiological measurement output 1308. The look-up table 1310 has a spectral characteristic input 1302 and generates a physiological measurement output 1308 utilizing the wavelength-dependent calibration data 1320. The wavelength determination function 1330 has parameter 1304 inputs and, in one embodiment, a feedback input of the physiological measurement 1308, and provides a sensor wavelength selection output 1338. The wavelength selection output 1338 provides a calibration data 1320 input for selecting wavelength-dependent portions of the calibration data 1320. As above, the look-up table 1310 and/or the calibration data 1320 may be replaced by or combined with mathematical formulas or algorithms. The wavelength control output 1338 is a feedback path to a controller 669 (FIG. 6) and/or drivers 662 (FIG. 6), for example, so as to modify the wavelength of a multiple-wavelength sensor 610 (FIG. 6). FIG. 13B, below, illustrates one advantageous pulse oximeter embodiment of the wavelength compensation relationship 1300.
  • [0062]
    FIG. 13B illustrates an oxygen saturation dependent wavelength compensation relationship 1301 having a null parameter input 1304 (FIG. 13A), i.e. no parameter is used, and a wavelength control output 1338 that is dependent on the SpO2 output 1308. In particular, the wavelength determination function 1330 has SpO2 1308 as input and generates a wavelength selection output 1338, accordingly. For example, the wavelength selection output 1338 determines particular red and IR wavelengths to be used for conventional pulse oximetry measurements and a corresponding one of a family of wavelength dependent calibration curves 1320. In this manner, sensor wavelength can be dynamically adjusted based upon saturation levels, e.g. a first red and/or IR wavelength may be used in low saturation conditions and a second red and/or IR wavelength may be used in normal saturation conditions.
  • [0063]
    FIG. 14 illustrates parameter compensation of pulse rate measurements. In this pulse oximetry embodiment, the compensation relationship 1400 includes a pulse rate calculation 1410 having a plethysmograph input 1402 and providing a pulse rate measurement output 1408. The pulse rate calculation 1410 also has one or more parameter inputs 1404, such as a manual input indicating the presence of an implant device, such as an IABP or a pacemaker, or the presence of an arrhythmia. The parameter input is used to alter the pulse rate calculation 1410 so as to derive a more accurate pulse rate measurement 1408. For example, the criteria for determining a physiologically acceptable pulse on the plethysmograph input 1402, such as aspects of the pulse shape, may be altered according to the parameter input 1404. Pulse rate calculations are described in U.S. Pat. No. 6,463,311 entitled “Plethysmograph Pulse Recognition Processor,” which is assigned to Masimo Corporation, Irvine, Calif. and incorporated by reference herein.
  • [0064]
    A parameter compensated physiological monitor has been disclosed in detail in connection with various embodiments. These embodiments are disclosed by way of examples only and are not to limit the scope of the claims that follow. One of ordinary skill in the art will appreciate many variations and modifications.
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US4892101 *24 Feb 19899 Ene 1990Physio-Control CorporationMethod and apparatus for offsetting baseline portion of oximeter signal
US5005576 *30 Mar 19899 Abr 1991Hewlett-Packard CompanyOptical probe
US5041187 *1 Oct 199020 Ago 1991Thor Technology CorporationOximeter sensor assembly with integral cable and method of forming the same
US5190039 *5 Dic 19902 Mar 1993Hitachi, Ltd.Apparatus and method for monitoring body organs
US5337744 *14 Jul 199316 Ago 1994Masimo CorporationLow noise finger cot probe
US5431170 *28 May 199111 Jul 1995Mathews; Geoffrey R.Pulse responsive device
US5482036 *26 May 19949 Ene 1996Masimo CorporationSignal processing apparatus and method
US5490505 *6 Oct 199313 Feb 1996Masimo CorporationSignal processing apparatus
US5494043 *4 May 199327 Feb 1996Vital Insite, Inc.Arterial sensor
US5533511 *5 Ene 19949 Jul 1996Vital Insite, IncorporatedApparatus and method for noninvasive blood pressure measurement
US5590649 *15 Abr 19947 Ene 1997Vital Insite, Inc.Apparatus and method for measuring an induced perturbation to determine blood pressure
US5602924 *9 Dic 199311 Feb 1997Theratechnologies Inc.Electronic stethescope
US5632272 *7 Oct 199427 May 1997Masimo CorporationSignal processing apparatus
US5638816 *7 Jun 199517 Jun 1997Masimo CorporationActive pulse blood constituent monitoring
US5638818 *1 Nov 199417 Jun 1997Masimo CorporationLow noise optical probe
US5645440 *16 Oct 19958 Jul 1997Masimo CorporationPatient cable connector
US5725480 *6 Mar 199610 Mar 1998Abbott LaboratoriesNon-invasive calibration and categorization of individuals for subsequent non-invasive detection of biological compounds
US5743262 *7 Jun 199528 Abr 1998Masimo CorporationBlood glucose monitoring system
US5758644 *7 Jun 19952 Jun 1998Masimo CorporationManual and automatic probe calibration
US5760910 *7 Jun 19952 Jun 1998Masimo CorporationOptical filter for spectroscopic measurement and method of producing the optical filter
US5769785 *7 Jun 199523 Jun 1998Masimo CorporationSignal processing apparatus and method
US5782757 *16 Oct 199521 Jul 1998Masimo CorporationLow-noise optical probes
US5785659 *17 May 199628 Jul 1998Vital Insite, Inc.Automatically activated blood pressure measurement device
US5791347 *14 Ago 199611 Ago 1998Vital Insite, Inc.Motion insensitive pulse detector
US5860919 *17 Abr 199719 Ene 1999Masimo CorporationActive pulse blood constituent monitoring method
US5890929 *3 Jun 19976 Abr 1999Masimo CorporationShielded medical connector
US5904654 *26 Feb 199618 May 1999Vital Insite, Inc.Exciter-detector unit for measuring physiological parameters
US5919134 *12 Ene 19986 Jul 1999Masimo Corp.Method and apparatus for demodulating signals in a pulse oximetry system
US5934925 *9 Abr 199710 Ago 1999Masimo CorporationPatient cable connector
US5940182 *1 Jun 199817 Ago 1999Masimo CorporationOptical filter for spectroscopic measurement and method of producing the optical filter
US6011986 *2 Feb 19984 Ene 2000Masimo CorporationManual and automatic probe calibration
US6027452 *26 Jun 199622 Feb 2000Vital Insite, Inc.Rapid non-invasive blood pressure measuring device
US6036642 *22 Jun 199814 Mar 2000Masimo CorporationSignal processing apparatus and method
US6045509 *19 Feb 19984 Abr 2000Vital Insite, Inc.Apparatus and method for measuring an induced perturbation to determine a physiological parameter
US6067462 *19 May 199823 May 2000Masimo CorporationSignal processing apparatus and method
US6081735 *3 Jul 199727 Jun 2000Masimo CorporationSignal processing apparatus
US6088607 *28 Ene 199711 Jul 2000Masimo CorporationLow noise optical probe
US6104938 *12 Jun 199715 Ago 2000Instrumentarium OyProcedure, apparatus and detector for the determination of fractional oxygen saturation
US6184521 *6 Ene 19986 Feb 2001Masimo CorporationPhotodiode detector with integrated noise shielding
US6206830 *17 Nov 199927 Mar 2001Masimo CorporationSignal processing apparatus and method
US6229856 *10 Abr 19988 May 2001Masimo CorporationMethod and apparatus for demodulating signals in a pulse oximetry system
US6236872 *25 Nov 199822 May 2001Masimo CorporationSignal processing apparatus
US6256523 *9 Jun 19983 Jul 2001Masimo CorporationLow-noise optical probes
US6263222 *6 Oct 199717 Jul 2001Masimo CorporationSignal processing apparatus
US6343224 *14 Oct 199929 Ene 2002Sensidyne, Inc.Reusable pulse oximeter probe and disposable bandage apparatus
US6349228 *23 Sep 199919 Feb 2002Masimo CorporationPulse oximetry sensor adapter
US6356774 *28 Sep 199912 Mar 2002Mallinckrodt, Inc.Oximeter sensor with encoded temperature characteristic
US6360114 *21 Mar 200019 Mar 2002Masimo CorporationPulse oximeter probe-off detector
US6371921 *1 Nov 199916 Abr 2002Masimo CorporationSystem and method of determining whether to recalibrate a blood pressure monitor
US6377829 *9 Dic 199923 Abr 2002Masimo CorporationResposable pulse oximetry sensor
US6388240 *2 Mar 200114 May 2002Masimo CorporationShielded optical probe and method having a longevity indication
US6397091 *30 Nov 199928 May 2002Masimo CorporationManual and automatic probe calibration
US6421549 *14 Jul 200016 Jul 2002Providence Health System-OregonAdaptive calibration pulsed oximetry method and device
US6515273 *10 Feb 20004 Feb 2003Masimo CorporationSystem for indicating the expiration of the useful operating life of a pulse oximetry sensor
US6519487 *5 Oct 200011 Feb 2003Sensidyne, Inc.Reusable pulse oximeter probe and disposable bandage apparatus
US6525386 *10 Mar 199825 Feb 2003Masimo CorporationNon-protruding optoelectronic lens
US6526300 *16 Jun 200025 Feb 2003Masimo CorporationPulse oximeter probe-off detection system
US6541756 *25 Ene 20011 Abr 2003Masimo CorporationShielded optical probe having an electrical connector
US6542764 *1 Dic 20001 Abr 2003Masimo CorporationPulse oximeter monitor for expressing the urgency of the patient's condition
US6580086 *19 Oct 199917 Jun 2003Masimo CorporationShielded optical probe and method
US6584336 *1 Mar 200024 Jun 2003Masimo CorporationUniversal/upgrading pulse oximeter
US6595316 *18 Jul 200122 Jul 2003Andromed, Inc.Tension-adjustable mechanism for stethoscope earpieces
US6597933 *17 Oct 200122 Jul 2003Masimo CorporationPulse oximetry sensor adapter
US6678543 *8 Nov 200113 Ene 2004Masimo CorporationOptical probe and positioning wrap
US6684090 *15 May 200127 Ene 2004Masimo CorporationPulse oximetry data confidence indicator
US6684091 *11 Ene 200127 Ene 2004Sensidyne, Inc.Reusable pulse oximeter probe and disposable bandage method
US6697656 *27 Jun 200024 Feb 2004Masimo CorporationPulse oximetry sensor compatible with multiple pulse oximetry systems
US6697658 *26 Jun 200224 Feb 2004Masimo CorporationLow power pulse oximeter
US6699194 *11 Abr 20002 Mar 2004Masimo CorporationSignal processing apparatus and method
US6714804 *21 Dic 200130 Mar 2004Masimo CorporationStereo pulse oximeter
US6721585 *17 Ago 200113 Abr 2004Sensidyne, Inc.Universal modular pulse oximeter probe for use with reusable and disposable patient attachment devices
US6725075 *23 Abr 200220 Abr 2004Masimo CorporationResposable pulse oximetry sensor
US6735459 *9 Sep 200211 May 2004Sensidyne, Inc.Reusable pulse oximeter probe and disposable bandage apparatus
US6745060 *3 Dic 20011 Jun 2004Masimo CorporationSignal processing apparatus
US6760607 *20 Dic 20016 Jul 2004Masimo CorporationRibbon cable substrate pulse oximetry sensor
US6850787 *26 Jun 20021 Feb 2005Masimo Laboratories, Inc.Signal component processor
US6850788 *28 Feb 20031 Feb 2005Masimo CorporationPhysiological measurement communications adapter
US6852083 *17 Ene 20028 Feb 2005Masimo CorporationSystem and method of determining whether to recalibrate a blood pressure monitor
US6861639 *3 Feb 20031 Mar 2005Masimo CorporationSystems and methods for indicating an amount of use of a sensor
US6898452 *22 Sep 200324 May 2005Masimo CorporationStereo pulse oximeter
US6920345 *24 Ene 200319 Jul 2005Masimo CorporationOptical sensor including disposable and reusable elements
US6985764 *2 May 200210 Ene 2006Masimo CorporationFlex circuit shielded optical sensor
US6993371 *22 Jul 200331 Ene 2006Masimo CorporationPulse oximetry sensor adaptor
US6996427 *18 Dic 20037 Feb 2006Masimo CorporationPulse oximetry data confidence indicator
US6999904 *5 Ago 200214 Feb 2006Masimo CorporationVariable indication estimator
US7003338 *8 Jul 200321 Feb 2006Masimo CorporationMethod and apparatus for reducing coupling between signals
US7003339 *3 Nov 200321 Feb 2006Masimo CorporationMethod and apparatus for demodulating signals in a pulse oximetry system
US7015451 *24 Ene 200321 Mar 2006Masimo CorporationPower supply rail controller
US7024233 *16 Sep 20044 Abr 2006Masimo CorporationPulse oximetry data confidence indicator
US7027849 *21 Nov 200311 Abr 2006Masimo Laboratories, Inc.Blood parameter measurement system
US7030749 *28 Oct 200418 Abr 2006Masimo CorporationParallel measurement alarm processor
US7039449 *19 Dic 20032 May 2006Masimo CorporationResposable pulse oximetry sensor
US7041060 *6 Sep 20059 May 2006Masimo CorporationRapid non-invasive blood pressure measuring device
US7044918 *27 Oct 200416 May 2006Masimo CorporationPlethysmograph pulse recognition processor
US7067893 *3 Ene 200327 Jun 2006Masimo CorporationOptoelectronic element with a non-protruding lens
USD361840 *21 Abr 199429 Ago 1995 Stethoscope head
USD393830 *16 Oct 199528 Abr 1998Masimo CorporationPatient cable connector
USRE38476 *27 Jun 200230 Mar 2004Masimo CorporationSignal processing apparatus
USRE38492 *11 Mar 20026 Abr 2004Masimo CorporationSignal processing apparatus and method
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US813544818 Nov 200513 Mar 2012Nellcor Puritan Bennett LlcSystems and methods to assess one or more body fluid metrics
US81756659 Mar 20078 May 2012Nellcor Puritan Bennett LlcMethod and apparatus for spectroscopic tissue analyte measurement
US82657249 Mar 200711 Sep 2012Nellcor Puritan Bennett LlcCancellation of light shunting
US82804699 Mar 20072 Oct 2012Nellcor Puritan Bennett LlcMethod for detection of aberrant tissue spectra
US83463279 Mar 20071 Ene 2013Covidien LpMethod for identification of sensor site by local skin spectrum data
US836422431 Mar 200929 Ene 2013Covidien LpSystem and method for facilitating sensor and monitor communication
US839194117 Jul 20095 Mar 2013Covidien LpSystem and method for memory switching for multiple configuration medical sensor
US841731010 Ago 20099 Abr 2013Covidien LpDigital switching in multi-site sensor
US86908649 Mar 20078 Abr 2014Covidien LpSystem and method for controlling tissue treatment
US892394420 Ago 201230 Dic 2014Covidien LpCancellation of light shunting
US906666029 Sep 200930 Jun 2015Nellcor Puritan Bennett IrelandSystems and methods for high-pass filtering a photoplethysmograph signal
US96425769 Dic 20149 May 2017Covidien LpCancellation of light shunting
US964907110 Jun 201516 May 2017Nellcor Puritan Bennett IrelandSystems and methods for high-pass filtering a photoplethysmograph signal
US20060253016 *18 Nov 20059 Nov 2006R Baker Clark JrSystems and methods to assess one or more body fluid metrics
US20080220512 *9 Mar 200711 Sep 2008Nellcor Puritan Bennett LlcTunable laser-based spectroscopy system for non-invasively measuring body water content
US20080221409 *9 Mar 200711 Sep 2008Nellcor Puritan Bennett LlcSystem and method for controlling tissue treatment
US20080221410 *9 Mar 200711 Sep 2008Nellcor Puritan Bennett LlcMethod for identification of sensor site by local skin spectrum data
US20080221412 *9 Mar 200711 Sep 2008Nellcor Puritan Bennett LlcMethod and apparatus for spectroscopic tissue analyte measurement
US20080221416 *9 Mar 200711 Sep 2008Nellcor Puritan Bennett LlcSystem and method for detection of macular degeneration using spectrophotometry
US20090247852 *31 Mar 20091 Oct 2009Nellcor Puritan Bennett LlcSystem and method for facilitating sensor and monitor communication
WO2013077808A1 *1 Nov 201230 May 2013Nitto Denko CorporationA method of obtaining a correction factor and a calibration device facilitating performance of said method
Clasificaciones
Clasificación de EE.UU.600/331
Clasificación internacionalA61B5/00
Clasificación cooperativaA61B5/14535, A61B2560/0252, A61B5/14551, A61B5/14539, A61B5/01
Clasificación europeaA61B5/145J, A61B5/1455N, A61B5/145H